Dowling & Yahnke’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $362K | Sell |
2,823
-57
| -2% | -$8.22K | 0.02% | 302 |
|
|
2022
Q2 | $406K | Sell |
2,880
-5
| -0.2% | -$714 | 0.02% | 291 |
|
|
2022
Q1 | $401K | Sell |
2,885
-21
| -0.7% | -$3.22K | 0.02% | 290 |
|
|
2021
Q4 | $507K | Sell |
2,906
-151
| -5% | -$25.2K | 0.02% | 276 |
|
|
2021
Q3 | $506K | Buy |
3,057
+2
| +0.1% | +$344 | 0.03% | 266 |
|
|
2021
Q2 | $550K | Buy |
3,055
+20
| +0.7% | +$3.65K | 0.03% | 254 |
|
|
2021
Q1 | $585K | Sell |
3,035
-1,223
| -29% | -$235K | 0.04% | 244 |
|
|
2020
Q4 | $860K | Hold |
4,258
| – | – | 0.06% | 209 |
|
|
2020
Q3 | $895K | Sell |
4,258
-238
| -5% | -$53K | 0.07% | 196 |
|
|
2020
Q2 | $986K | Buy |
4,496
+162
| +4% | +$32.4K | 0.08% | 187 |
|
|
2020
Q1 | $751K | Buy |
4,334
+64
| +1% | +$10.6K | 0.07% | 191 |
|
|
2019
Q4 | $656K | Sell |
4,270
-211
| -5% | -$31.5K | 0.05% | 219 |
|
|
2019
Q3 | $681K | Sell |
4,481
-25
| -0.6% | -$3.95K | 0.06% | 213 |
|
|
2019
Q2 | $690K | Buy |
4,506
+189
| +4% | +$28.9K | 0.06% | 214 |
|
|
2019
Q1 | $693K | Buy |
4,317
+527
| +14% | +$81.8K | 0.07% | 191 |
|
|
2018
Q4 | $628K | Hold |
3,790
| – | – | 0.07% | 183 |
|
|
2018
Q3 | $570K | Hold |
3,790
| – | – | 0.05% | 216 |
|
|
2018
Q2 | $513K | Hold |
3,790
| – | – | 0.05% | 224 |
|
|
2018
Q1 | $504K | Sell |
3,790
-20
| -0.5% | -$2.69K | 0.05% | 227 |
|
|
2017
Q4 | $567K | Sell |
3,810
-141
| -4% | -$19.2K | 0.05% | 225 |
|
|
2017
Q3 | $521K | Hold |
3,951
| – | – | 0.05% | 212 |
|
|
2017
Q2 | $526K | Sell |
3,951
-373
| -9% | -$50.3K | 0.06% | 211 |
|
|
2017
Q1 | $583K | Buy |
4,324
+170
| +4% | +$22K | 0.06% | 207 |
|
|
2016
Q4 | $499K | Sell |
4,154
-89
| -2% | -$10.5K | 0.06% | 210 |
|
|
2016
Q3 | $531K | Buy |
4,243
+48
| +1% | +$6.29K | 0.06% | 199 |
|
|
2016
Q2 | $581K | Sell |
4,195
-120
| -3% | -$15.6K | 0.07% | 190 |
|
|
2016
Q1 | $544K | Buy |
4,315
+100
| +2% | +$12.7K | 0.07% | 194 |
|
|
2015
Q4 | $535K | Sell |
4,215
-241
| -5% | -$29.9K | 0.07% | 192 |
|
|
2015
Q3 | $515K | Buy |
4,456
+140
| +3% | +$15.7K | 0.07% | 188 |
|
|
2015
Q2 | $449K | Hold |
4,316
| – | – | 0.06% | 202 |
|
|
2015
Q1 | $476K | Sell |
4,316
-8
| -0.2% | -$868 | 0.06% | 199 |
|
|
2014
Q4 | $451K | Sell |
4,324
-150
| -3% | -$15K | 0.06% | 203 |
|
|
2014
Q3 | $430K | Buy |
4,474
+600
| +15% | +$54.3K | 0.06% | 194 |
|
|
2014
Q2 | $354K | Sell |
3,874
-383
| -9% | -$34.3K | 0.05% | 222 |
|
|
2014
Q1 | $375K | Sell |
4,257
-135
| -3% | -$11.9K | 0.05% | 213 |
|
|
2013
Q4 | $407K | Sell |
4,392
-603
| -12% | -$54.3K | 0.06% | 198 |
|
|
2013
Q3 | $408K | Sell |
4,995
-345
| -6% | -$29.1K | 0.06% | 189 |
|
|
2013
Q2 | $444K | Buy |
+5,340
| New | +$459K | 0.07% | 177 |
|
Other funds holding CLX
Dowling & Yahnke's CLX Position: Q3 2022 in Review
Dowling & Yahnke reduced its Clorox (CLX) stake by 2% in Q3 2022, selling an estimated $8.22K and leaving 2,823 shares worth $362K. The position accounts for 0.02% of the portfolio, ranked #302.
Dowling & Yahnke first reported a position in CLX in Q2 2013 and has held it in 38 quarters since. The position peaked at $986K in Q2 2020. 1,046 funds tracked by Wall St. Rank hold CLX as of Q3 2022.
- Dowling & Yahnke held 2,823 shares of Clorox worth $362K as of Q3 2022.
- Dowling & Yahnke sold 57 Clorox shares in Q3 2022, an estimated $8.22K.
- Clorox made up 0.02% of Dowling & Yahnke's portfolio in Q3 2022, its #302 holding.
- Dowling & Yahnke first reported a position in Clorox in Q2 2013 and has held it in 38 quarters since.
- Dowling & Yahnke's Clorox position peaked at $986K in Q2 2020.
- 1,046 funds tracked by Wall St. Rank held Clorox as of Q3 2022.
Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.